Generation of an iPSC cell line (VANYHHi001-A) from a patient with cardiac arrythmias carrying CACNA1D, SCN5A, and DSP variants

被引:0
|
作者
Sleiman, Yvonne [1 ]
Reisqs, Jean-Baptiste [1 ]
Tan, Reina Bianca [2 ]
Cecchin, Frank [2 ]
Chahine, Mohamed [3 ,4 ]
Boutjdir, Mohamed [1 ,5 ,6 ]
机构
[1] VA New York Harbor Healthcare Syst, Cardiovasc Res Program, Brooklyn, NY 11209 USA
[2] NYU Grossman Sch Med, Dept Pediat, Div Pediat Cardiol, New York, NY USA
[3] Inst Univ Sante Mentale Quebec, CERVO Brain Res Ctr, Quebec City, PQ, Canada
[4] Univ Laval, Fac Med, Dept Med, Quebec City, PQ G1V 06A, Canada
[5] SUNY Downstate Hlth Sci Univ, Dept Med Cell Biol & Pharmacol, Brooklyn, NY USA
[6] NYU, Grossman Sch Med, Dept Med, New York, NY USA
关键词
Progressive cardiac conduction defect; Sinoatrial node dysfunction; Induced pluripotent stem cells; SCN5A; CACNA1D; DSP;
D O I
10.1016/j.scr.2024.103608
中图分类号
Q813 [细胞工程];
学科分类号
摘要
Progressive cardiac conduction defect often associated with variants in sodium voltage-gated channel SCN5A gene and variants in the L-type calcium voltage-gated channel CACNA1D gene are implicated in sinoatrial node dysfunction. We generated an induced pluripotent stem cell line (iPSC) from a 13-year-old patient with history of conduction system disease and ventricular tachycardia, carrying variants in SCN5A (c.2618C > G), CACNA1D (c.3786G > T), and DSP (c.1582C > G). The generated iPSC line exhibited pluripotency markers, differentiated into the three embryonic germ layers, and maintained a normal karyotype. This iPSC line offers insights into the pathophysiological mechanisms of cardiac arrhythmias and personalized therapies development.
引用
收藏
页数:5
相关论文
共 43 条
  • [21] Generation and characterization of the human induced pluripotent stem cell (hiPSC) line NCUFi001-A from a patient carrying KCNQ1 G314S mutation
    Lavra, Luca
    Magi, Fiorenza
    Ulivieri, Alessandra
    Morgante, Alessandra
    Paulis, Marianna
    Sala, Luca
    Pedrazzini, Matteo
    Polisca, Patrizio
    Rocchetti, Marcella
    Calo, Leonardo
    Sciacchitano, Salvatore
    Salehi, Leila B.
    STEM CELL RESEARCH, 2021, 54
  • [22] Generation of D1-1 TALEN isogenic control cell line from Dravet syndrome patient iPSCs using TALEN-mediated editing of the SCN1A gene
    Tanaka, Yasuyoshi
    Sone, Takefumi
    Higurashi, Norimichi
    Sakuma, Tetsushi
    Suzuki, Sadafumi
    Ishikawa, Mitsuru
    Yamamoto, Takashi
    Mitsui, Jun
    Tsuji, Hitomi
    Okano, Hideyuki
    Hirose, Shinichi
    STEM CELL RESEARCH, 2018, 28 : 100 - 104
  • [23] Generation and characterization of PBMCs-derived human induced pluripotent stem cell (iPSC) line SDQLCHi055-A from a patient with NEDSDV carrying a heterozygote mutation in the CTNNB1 gene
    Yang, Yanan
    Liu, Chen
    Liu, Ning
    Yang, Xiaomeng
    Liu, Yi
    Gai, Zhongtao
    STEM CELL RESEARCH, 2024, 76
  • [24] Generation of the induced pluripotent stem cell line (ZSPHARi001-A) from a patient with recessive dystrophic epidermolysis bullosa carrying compound heterozygous mutation in the COL7A1 gene
    Zhang, Yeye
    Fan, Jun
    Lu, Guangzhao
    Xu, Genying
    Lv, Qianzhou
    STEM CELL RESEARCH, 2022, 60
  • [25] Generation of a human induced pluripotent stem cell line (NCCDFWi001-A) from a Marfan syndrome patient carrying two FBN1 variants (c.2613A > C and c.684_736+4del)
    Ma, Baihui
    Luo, Mingyao
    Yang, Hang
    Li, Tianjiao
    Liu, Weiwei
    Xu, Faxiang
    Shu, Chang
    Chen, Guokai
    Zhou, Zhou
    STEM CELL RESEARCH, 2020, 42
  • [26] Generation of the induced pluripotent stem cell(iPSC) line (AHQUi001-A) from a patient with familial hypertriglyceridemia (FHTG) carrying a heterozygous p.C310R (c.928 T > C) mutation in LPL gene
    Sun, Xiaofang
    Zhou, Xiang
    Xiao, Xinhua
    Chi, Jingwei
    Dong, Bingzi
    Wang, Yangang
    STEM CELL RESEARCH, 2020, 45
  • [27] Generation of human induced pluripotent stem cell (hiPSC) line UOMi001-A from a patient with Leigh-like syndrome harbouring compound heterozygous variants in ECHS1 gene
    Sequiera, Glen Lester
    Rockman-Greenberg, Cheryl
    Dhingra, Sanjiv
    STEM CELL RESEARCH, 2020, 48
  • [28] Generation of an induced pluripotent stem cell (iPSC) line from a patient with GEFS plus carrying a STX1B (p.Lys45delinsArgMetCysIleGlu and p. Leu46Met) mutation
    Haag, Carolin
    Uysal, Betuel
    Marquetand, Justus
    Loeffler, Heidi
    Mau-Holzmann, Ulrike A.
    Lerche, Holger
    Schwarz, Niklas
    STEM CELL RESEARCH, 2023, 67
  • [29] Generation of an induced pluripotent stem cell (iPSC) line from a patient with maturity-onset diabetes of the young type 3 (MODY3) carrying a hepatocyte nuclear factor 1-alpha (HNF1A) mutation
    Griscelli, Frank
    Ezanno, Helene
    Soubeyrand, Mathis
    Feraud, Olivier
    Oudrhiri, Noufissa
    Bonnefond, Amelie
    Turhan, Ali G.
    Froguel, Philippe
    Bennaceur-Griscelli, Annelise
    STEM CELL RESEARCH, 2018, 29 : 56 - 59
  • [30] Generation of an induced pluripotent stem cell line from a patient with conduction disease and recurrent ventricular fibrillation with a sodium voltage-gated channel alpha subunit 5 (SCN5A) gene c.392+3A > G splice-site variant
    Li, Serena
    Fraser, Stuart
    Lim, Seakcheng
    Singer, Emma S.
    Parker, Jeremy D. K.
    Crowe, Joshua
    Bagnall, Richard D.
    Laksman, Zachary
    Semsarian, Christopher
    STEM CELL RESEARCH, 2023, 71